Teva Pharmaceutical Industries Ltd (TEVA)
18.76
+0.31
(+1.68%)
USD |
NYSE |
Nov 04, 13:16
Teva Pharmaceutical Industries Debt to Equity Ratio: 2.931 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.931 |
| March 31, 2024 | 2.699 |
| December 31, 2023 | 2.642 |
| September 30, 2023 | 2.883 |
| June 30, 2023 | 2.932 |
| March 31, 2023 | 2.632 |
| December 31, 2022 | 2.718 |
| September 30, 2022 | 2.426 |
| June 30, 2022 | 2.444 |
| March 31, 2022 | 2.453 |
| December 31, 2021 | 2.242 |
| September 30, 2021 | 2.269 |
| June 30, 2021 | 2.434 |
| March 31, 2021 | 2.498 |
| December 31, 2020 | 2.585 |
| September 30, 2020 | 2.671 |
| June 30, 2020 | 1.896 |
| March 31, 2020 | 1.929 |
| December 31, 2019 | 1.926 |
| September 30, 2019 | 1.954 |
| June 30, 2019 | 2.034 |
| March 31, 2019 | 1.943 |
| December 31, 2018 | 1.966 |
| September 30, 2018 | 1.663 |
| June 30, 2018 | 1.686 |
| Date | Value |
|---|---|
| March 31, 2018 | 1.652 |
| December 31, 2017 | 1.871 |
| September 30, 2017 | 1.210 |
| June 30, 2017 | 1.252 |
| March 31, 2017 | 1.018 |
| December 31, 2016 | 1.074 |
| September 30, 2016 | 1.049 |
| June 30, 2016 | 0.3621 |
| March 31, 2016 | 0.3351 |
| December 31, 2015 | 0.334 |
| September 30, 2015 | 0.513 |
| June 30, 2015 | 0.5434 |
| March 31, 2015 | 0.4867 |
| December 31, 2014 | 0.443 |
| September 30, 2014 | 0.4506 |
| June 30, 2014 | 0.4745 |
| March 31, 2014 | 0.5136 |
| December 31, 2013 | 0.5403 |
| September 30, 2013 | 0.5647 |
| June 30, 2013 | 0.5791 |
| March 31, 2013 | 0.5573 |
| December 31, 2012 | 0.6464 |
| September 30, 2012 | 0.6013 |
| June 30, 2012 | 0.6173 |
| March 31, 2012 | 0.63 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
1.896
Minimum
Jun 2020
2.932
Maximum
Jun 2023
2.485
Average
2.498
Median
Mar 2021
Debt to Equity Ratio Benchmarks
| Amicus Therapeutics Inc | 2.935 |
| Compugen Ltd | 0.00 |
| Pluri Inc | 250.28 |
| Can Fite Biofarma Ltd | 0.00 |
| BiomX Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 41.34B |
| Total Liabilities (Quarterly) | 34.78B |
| Shareholders Equity (Quarterly) | 6.359B |
| Current Ratio | 0.8922 |
| Net Debt Paydown Yield | 2.23% |